These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 5012168

  • 1. Relationship between the oxygen affinity and in vitro sickling propensity of carbamylated sickle erythrocytes.
    Diederich D.
    Biochem Biophys Res Commun; 1972 Feb 16; 46(3):1255-61. PubMed ID: 5012168
    [No Abstract] [Full Text] [Related]

  • 2. Cyanate as an inhibitor of red-cell sickling.
    Cerami A.
    N Engl J Med; 1972 Oct 19; 287(16):807-12. PubMed ID: 4560520
    [No Abstract] [Full Text] [Related]

  • 3. Potassium cyanate as an inhibitor of the sickling of erythrocytes in vitro.
    Cerami A, Manning JM.
    Proc Natl Acad Sci U S A; 1971 Jun 19; 68(6):1180-3. PubMed ID: 5288366
    [Abstract] [Full Text] [Related]

  • 4. The effects of cyanate in vitro on red blood cell metabolism and function in sickle cell anemia.
    De Furia FG, Miller DR, Cerami A, Manning JM.
    J Clin Invest; 1972 Mar 19; 51(3):566-74. PubMed ID: 5011101
    [Abstract] [Full Text] [Related]

  • 5. Effects of urea and cyanate on sickling in vitro.
    Segel GB, Feig SA, Mentzer WC, McCaffrey RP, Wells R, Bunn HF, Shohet SB, Nathan DG.
    N Engl J Med; 1972 Jul 13; 287(2):59-64. PubMed ID: 5031386
    [No Abstract] [Full Text] [Related]

  • 6. Cyanate and sickle-cell disease.
    Cerami A, Peterson CM.
    Sci Am; 1975 Apr 13; 232(4):44-50. PubMed ID: 1114310
    [No Abstract] [Full Text] [Related]

  • 7. Chemical and biological aspects of the inhibition of red blood cell sickling by cyanate.
    Manning JM, Cerami A, Gillette PN, De Furia FG, Miller DR.
    Adv Exp Med Biol; 1972 Apr 13; 28():253-60. PubMed ID: 5085171
    [No Abstract] [Full Text] [Related]

  • 8. Effects of cyanate and 2,3-diphosphoglycerate on sickling. Relationship to oxygenation.
    Jensen M, Bunn HF, Halikas G, Kan YW, Nathan DG.
    J Clin Invest; 1973 Oct 13; 52(10):2542-7. PubMed ID: 4729047
    [Abstract] [Full Text] [Related]

  • 9. The clinical use of cyanate in sickling.
    Ranney HM.
    N Engl J Med; 1972 Jul 13; 287(2):98-100. PubMed ID: 4624186
    [No Abstract] [Full Text] [Related]

  • 10. Carbamylation of the chains of hemoglobin S by cyanate in vitro and in vivo.
    Njikam N, Jones WM, Nigen AM, Gillette PN, Williams RC, Manning JM.
    J Biol Chem; 1973 Dec 10; 248(23):8052-6. PubMed ID: 4752945
    [No Abstract] [Full Text] [Related]

  • 11. Prostaglandin E2 effects on oxygen affinity by sickle erythrocytes.
    Rabinowitz I, Wolf PL, Shikuma N, Berman S.
    Prostaglandins; 1974 Aug 25; 7(4):309-17. PubMed ID: 4415346
    [No Abstract] [Full Text] [Related]

  • 12. The effect of hemoglobin carbamylation on the survival of human sickle cell erythrocytes in rats.
    Castro O, Orlin J, Finch SC.
    Yale J Biol Med; 1974 Mar 25; 47(1):55-60. PubMed ID: 4825087
    [No Abstract] [Full Text] [Related]

  • 13. Solubility changes observed in sickle cell hemoglobin as the amino groups are carbamylated.
    Vedvick TS, Koenig HM, Itano HA.
    Proc Soc Exp Biol Med; 1974 Oct 25; 147(1):255-8. PubMed ID: 4438331
    [No Abstract] [Full Text] [Related]

  • 14. Some comparative aspects of carbamylation of human blood and of hemoglobin with cyanate and carbamyl phosphate.
    Carreras-Barnes J, Diederich DA, Grisolia S.
    Eur J Biochem; 1972 May 25; 27(1):103-8. PubMed ID: 5049047
    [No Abstract] [Full Text] [Related]

  • 15. The effect of alteration of intracellular 2,3-DPG concentration upon oxygen binding of intact erythrocytes containing normal and mutant hemoglobins.
    Lian CY, Roth S, Harkness DR.
    Biochem Biophys Res Commun; 1971 Oct 01; 45(1):151-8. PubMed ID: 5139918
    [No Abstract] [Full Text] [Related]

  • 16. Oxygen affinity independent action of cyanate and 2,3 DPG on sickling.
    Jensen MC, Bunn HF, Halikas GC, Nathan DG.
    Adv Exp Med Biol; 1972 Oct 01; 28():297-302. PubMed ID: 5085173
    [No Abstract] [Full Text] [Related]

  • 17. Reticulocyte survival in sickle cell anemia: effect of cyanate.
    Alter BP, Kan YW, Nathan DG.
    Blood; 1972 Nov 01; 40(5):733-9. PubMed ID: 5078929
    [No Abstract] [Full Text] [Related]

  • 18. Kinetics of the carbamylation of the amino groups of sickle cell hemoglobin by cyanate.
    Lee CK, Manning JM.
    J Biol Chem; 1973 Aug 25; 248(16):5861-5. PubMed ID: 4723918
    [No Abstract] [Full Text] [Related]

  • 19. Deoxyhemoglobin S: solubility vs. erythrocyte sickling.
    Vedvick TS, Koenig HM, Itano HA.
    Clin Biochem; 1975 Aug 25; 8(4):288-90. PubMed ID: 1157297
    [No Abstract] [Full Text] [Related]

  • 20. Cyanate and sickling.
    Charache S, Diederich D.
    N Engl J Med; 1971 Nov 11; 285(20):1147. PubMed ID: 5095746
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.